Clin2
NCT07352072Likely a fitNot yet recruiting

Bleeding and clotting risks in COVID-19 patients on ECMO

VV ECMOBleedingThrombosisTransfusion Adverse ReactionCOVID-19

Part of Heart & circulation, Infections, Lungs & breathing clinical trials.

This study looks at risks of bleeding, blood clots, and blood transfusion needs in patients with COVID-19 who are on a life-support machine called ECMO. If you qualify, the study may help doctors better manage these risks.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
50 people
Ages
Any age
Study type
Observational

Who can take part

  • You must be 18 years old or older.
  • You must have tested positive for COVID-19 using a PCR test.
  • You must be receiving treatment with a machine called ECMO (which adds oxygen to your blood) at this specific hospital.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07580469Not yet recruiting
Platelets and lung-support machine study

This study looks at how platelets (the cells that help clot blood) behave in patients on a lung-support machine called ECMO. By taking blood samples, researchers hope to better understand clotting issues that can occur during ECMO support.

Toulouse
NCT05334615Recruiting
Study of blood clot problems after COVID or flu

This study looks at blood clot–related complications after COVID-19 (and in some cases flu) in adults admitted to the hospital. It may help doctors better understand and manage these complications.

Iowa City, Iowa
NCT07016685Recruiting
ECMO outcomes after emergency chest surgery

This study looks at how well patients recover after needing a heart-lung bypass machine (VV-ECMO) during or right after emergency chest surgery. It aims to understand what affects their prognosis.

Amiens
NCT04377490Recruiting
Study of blood clots in hospitalized COVID-19 patients

This study looks at how often blood clot–related problems happen in people hospitalized with serious COVID-19 lung illness. It may help doctors understand risks and improve care for patients in the hospital.

Amiens
NCT06442267Recruiting· Phase 4
Comparing blood thinners for ECMO support

This trial compares three different blood thinners (heparin, argatroban, and enoxaparin) used during ECMO support. It aims to find the safest and most effective way to prevent blood clots while on ECMO.

Vienna, State of Vienna
NCT05562505Recruiting
Using ECMO to help you breathe, sit up, and come off a ventilator

This trial tests whether a heart-lung machine called venovenous ECMO can help people with severe breathing failure get less sedated, get extubated (have the breathing tube removed), and start moving. It’s for certain adults who are on a ventilator for a short time and have specific oxygenation problems.

Darlinghurst, New South Wales

Hear when a new Bleeding trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.